Cryocath to present at Leerink Swann - Rhythm Revival: Atrial Fibrillation Roundtable Conference



    Toronto Stock Exchange Symbol: CYT
    www.cryocath.com

    MONTREAL, June 5 /CNW/ - CryoCath Technologies Inc. (TSX: CYT), the
global leader in cryotherapy products to treat cardiovascular disease, today
announced that Jan Keltjens, President and CEO of CryoCath, will present at
the Leerink Swann - Rhythm Revival: Atrial Fibrillation Roundtable Conference
at the Grand Hyatt in New York City on Wednesday, June 6. Mr. Keltjens will be
part of an expert panel on device based therapies for atrial fibrillation at
2:15 p.m., followed by a corporate presentation at 3:00 p.m. that will
highlight Arctic Front(R), CryoCath's minimally invasive cryo-balloon catheter
designed specifically to treat paroxysmal atrial fibrillation.

    About CryoCath

    CryoCath - www.cryocath.com - is a medical technology company that leads
the world in cryotherapy products to treat cardiovascular disease. With a
priority focus on providing physicians with a complete solution of catheter
and surgical products to treat cardiac arrhythmias, CryoCath has multiple
products approved in the U.S., across Europe and several ROW countries. The
Company is developing additional products to expand its pipeline of products
to treat cardiac arrhythmias.

    This press release includes "forward-looking statements" that are subject
to risks and uncertainties, including with respect to the timing of regulatory
trials and their outcome. For information identifying legislative or
regulatory, economic, climatic, currency, technological, competitive and other
important factors that could cause actual results to differ materially from
those anticipated in the forward looking statements, see CryoCath's annual
report available at www.sedar.com under the heading Risks and Uncertainties in
the Management's Discussion and Analysis section.

    %SEDAR: 00015053EF




For further information:

For further information: visit our website at www.cryocath.com, or
contact: Michael Moore, Investor Relations, Phone: (416) 815-0700 ext. 241,
Fax: (416) 815-0080, E-mail: mmoore@equicomgroup.com

Organization Profile

CRYOCATH TECHNOLOGIES INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890